Results 171 to 180 of about 6,101 (249)

Spinal muscular atrophy in the era of newborn screening: how the classification could change. [PDF]

Front Neurol
Varone A, Esposito G, Bitetti I.
europepmc   +1 more source

Postmarketing adverse events associated with onasemnogene abeparvovec: a real-world pharmacovigilance study. [PDF]

Orphanet J Rare Dis
Chen T, Chen Q, Ye J, Wu Y, Liu T, Zhang Y.   +5 more
europepmc   +1 more source

Future avenues for therapy development for spinal muscular atrophy [PDF]

, 2018
Groen, Ewout
core   +1 more source

Nusinersen for children with type I spinal muscular atrophy: 4 years' clinical experience in Turkish cohort. [PDF]

Front Neurol
Bektaş Ö, Gülşen M, Dursun OB, Tekin A, Yüksel D, Demir E, Öztürk G, Saltık S, Hergüler Ö, Özçelik AA, Tan H, Özgör B, Ekici A, Yüksel MF, Şahin S, Duman Ö, Kömür M, Baydan F, Yıldız EP, Kara B, Yiş U, Kanmaz S, Çarman KB, Arslan EA, Canpolat M, Güven AS, Öztuncer G, Ünalp A, Ardıçlı D, Karaduman AA, Zararsız G, Deda G, Turkish SMA Study Group.   +32 more
europepmc   +1 more source

Advances in therapy for spinal muscular atrophy: promises and challenges [PDF]

, 2018
Gillingwater, Thomas, Groen, Ewout, Talbot, Kevin   +2 more
core   +1 more source

Healthcare Resource Utilization, Economic Burden, and Multi-Level Medical Security System for Individuals with Spinal Muscular Atrophy in Shaanxi Province, China. [PDF]

Healthcare (Basel)
Zhao M, Ding S, Zhao Y, Lin C, Han Y.
europepmc   +1 more source

Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy. [PDF]

Brain Behav
Bahadır Şenol H, Yıldız G, Polat Aİ, Aydın A, Hız AS, Soylu A, Yiş U.   +6 more
europepmc   +1 more source

Considerations for repetitive intrathecal procedures in long-term nusinersen treatment for non-ambulatory spinal muscular atrophy. [PDF]

Sci Rep
Lee HS, Lee H, Lee YM, Kim S.
europepmc   +1 more source

Fiducial-marked laminectomy window for intrathecal medication administration after spinal fusion: illustrative case. [PDF]

J Neurosurg Case Lessons
Still MEH, Blatt JE.
europepmc   +1 more source

Spinal presentations in children with type 1 spinal muscular atrophy on nusinersen treatment across the SMA-REACH UK network: a retrospective national observational study. [PDF]

BMJ Open
Abbott L, Main M, Wolfe A, Rohwer A, Baranello G, Munot P, Manzur A, Muntoni F, Scoto M, SMA-REACH UK Network Physiotherapists.   +9 more
europepmc   +1 more source